[go: up one dir, main page]

WO2007079173A3 - Novel 2-heteroaryloxy-phenol derivatives as antibacterial agents - Google Patents

Novel 2-heteroaryloxy-phenol derivatives as antibacterial agents Download PDF

Info

Publication number
WO2007079173A3
WO2007079173A3 PCT/US2006/049473 US2006049473W WO2007079173A3 WO 2007079173 A3 WO2007079173 A3 WO 2007079173A3 US 2006049473 W US2006049473 W US 2006049473W WO 2007079173 A3 WO2007079173 A3 WO 2007079173A3
Authority
WO
WIPO (PCT)
Prior art keywords
heteroaryloxy
novel
antibacterial agents
phenol derivatives
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2006/049473
Other languages
French (fr)
Other versions
WO2007079173A2 (en
Inventor
Liren Huang
Joanna Clancy
Christopher Taylor
Weitao Pan
Alenka Tomazic
W James Jackson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Emergent Biosolutions Inc
Original Assignee
Emergent Biosolutions Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emergent Biosolutions Inc filed Critical Emergent Biosolutions Inc
Publication of WO2007079173A2 publication Critical patent/WO2007079173A2/en
Publication of WO2007079173A3 publication Critical patent/WO2007079173A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18One oxygen or sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/34One oxygen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/18Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/32Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Antimicrobial compounds, compositions and methods of treatment administering same, of 2-heteroaryloxyphenol, as well as methods for their preparation and formation, wherein the compounds are generally of Formula 1.
PCT/US2006/049473 2005-12-30 2006-12-29 Novel 2-heteroaryloxy-phenol derivatives as antibacterial agents Ceased WO2007079173A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85333405P 2005-12-30 2005-12-30
US60/853,334 2005-12-30

Publications (2)

Publication Number Publication Date
WO2007079173A2 WO2007079173A2 (en) 2007-07-12
WO2007079173A3 true WO2007079173A3 (en) 2007-11-15

Family

ID=38228847

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/049473 Ceased WO2007079173A2 (en) 2005-12-30 2006-12-29 Novel 2-heteroaryloxy-phenol derivatives as antibacterial agents

Country Status (1)

Country Link
WO (1) WO2007079173A2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8889730B2 (en) 2012-04-10 2014-11-18 Pfizer Inc. Indole and indazole compounds that activate AMPK
US9394285B2 (en) 2013-03-15 2016-07-19 Pfizer Inc. Indole and indazole compounds that activate AMPK

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201008209D0 (en) * 2010-05-17 2010-06-30 Senexis Ltd Compounds

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4266063A (en) * 1979-12-17 1981-05-05 E. I. Du Pont De Nemours And Company Process for preparing substituted pyridinyloxy ether intermediate
US5186735A (en) * 1986-03-07 1993-02-16 Dowelanco Derivatives of 4-((aryloxy)phenoxy)alkenols and their herbicidal uses
US6281226B1 (en) * 1997-10-29 2001-08-28 Smithkline Beecham P.L.C. Pleuromutilin derivatives as antimicrobials
US20030114674A1 (en) * 2000-04-04 2003-06-19 Gerald Brooks 2-Hydroxy-mutilin carbamate derivatives for antibacterial use
US6946458B2 (en) * 1999-07-22 2005-09-20 University Of South Florida N-thiolated beta-lactams: novel antibacterial agents for methicillin-resistant Staphylococcus aureus
US6951880B2 (en) * 2002-05-16 2005-10-04 Genelabs Technologies, Inc. Aryl and heteroaryl compounds as antibacterial and antifungal agents

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4266063A (en) * 1979-12-17 1981-05-05 E. I. Du Pont De Nemours And Company Process for preparing substituted pyridinyloxy ether intermediate
US5186735A (en) * 1986-03-07 1993-02-16 Dowelanco Derivatives of 4-((aryloxy)phenoxy)alkenols and their herbicidal uses
US6281226B1 (en) * 1997-10-29 2001-08-28 Smithkline Beecham P.L.C. Pleuromutilin derivatives as antimicrobials
US6946458B2 (en) * 1999-07-22 2005-09-20 University Of South Florida N-thiolated beta-lactams: novel antibacterial agents for methicillin-resistant Staphylococcus aureus
US20030114674A1 (en) * 2000-04-04 2003-06-19 Gerald Brooks 2-Hydroxy-mutilin carbamate derivatives for antibacterial use
US6951880B2 (en) * 2002-05-16 2005-10-04 Genelabs Technologies, Inc. Aryl and heteroaryl compounds as antibacterial and antifungal agents

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8889730B2 (en) 2012-04-10 2014-11-18 Pfizer Inc. Indole and indazole compounds that activate AMPK
US9394285B2 (en) 2013-03-15 2016-07-19 Pfizer Inc. Indole and indazole compounds that activate AMPK

Also Published As

Publication number Publication date
WO2007079173A2 (en) 2007-07-12

Similar Documents

Publication Publication Date Title
WO2006032342A3 (en) Carbonyl compound-containing drug and the use thereof
WO2004074244A3 (en) Pyrimidine compounds
GEP20115174B (en) Triazolopyrazine derivatives useful as anti-cancer agents
WO2006073457A3 (en) Bioactive compounds and methods of uses thereof
WO2007148185A3 (en) Substituted 3 -amino- pyrrolidino-4 -lactams as dpp inhibitors
TW200716519A (en) Benzoyl-substituted serineamides
WO2007120980A3 (en) 2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases
WO2002102793A3 (en) Quinazolinediones as antibacterial agents
WO2007064954A3 (en) Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents
WO2007126900A3 (en) Antifungal agents
WO2006005609A3 (en) Substituted oxindol derivatives and medicaments containing the same
WO2007067559A3 (en) Antibacterial agents
WO2006099943A8 (en) Amide-substituted 8-n-benzimidazoles, method for the production thereof, and use of the same as medicaments
WO2010047737A3 (en) Antimicrobial indoline compounds for treatment of bacterial infections
WO2007131907A3 (en) 1h-indol-5-yl-piperazin-1-yl-methanone derivatives
WO2007001335A3 (en) Ramoplanin derivatives possessing antibacterial activity
WO2008071961A8 (en) 2-quinolinone and 2-quinoxalinone- derivatives and their use as antibacterial agents
WO2006055070A3 (en) Novel lincomycin derivatives possessing antibacterial activity
WO2007138112A3 (en) Compounds that interact with ion channels, in particular with ion channels from the kv family
WO2006120563A3 (en) Antibacterial agents
WO2007066336A3 (en) Chemical derivatives of jasmonate, pharmaceutical compositions and methods of use thereof
WO2007009724A3 (en) Cycloalkane-substituted pyrazoline derivatives, their preparation and use as medicaments
WO2004087652A3 (en) Imidazotriazine compounds
WO2007066337A3 (en) Jasmonate derivatives, pharmaceutical compositions and methods of use thereof
WO2006077024A3 (en) 5-aminoindole derivatives

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06848269

Country of ref document: EP

Kind code of ref document: A2